LEAH Labs

Curing Cancer in Dogs (RAISING VIA VIP LINK ONLY RIGHT NOW)
Rochester, 
MN
Investment type:
Equity
(SAFE)
Target raise:
$100,000
 - $535,000
Minimum investment:​
$100
End date:
May 01, 2022
Share
Share on facebook
Share on twitter
Share on linkedin
Share on email
Highlights

  • We’re developing CAR-T cell therapy for dogs. It’s already curing human patients with lymphoma.
  • We’ve built our MVP and are testing its safety right now. Preliminary data looks great!
  • Booming companion animal market. Over 90M dogs in the USA, $100B+ yearly spend in the space.
  • We’re a team of world leading experts in gene editing, immunotherapy, and veterinary oncology.
Our Story

LEAH Labs uses next generation technology to reprogram immune cells into cancer fighting machines.

Our Ambition

In 5 years, we hope LEAH Labs has the only treatment in canine oncology that can CURE cancer. We hope to have diversified our portfolio and now treat multiple cancer types. We hope the data we have generated and the platform we have built are licensed to a leading human immuno-oncology company. We hope we've expanded and have cell therapy products across a range of disease. While these projections cannot be guaranteed, we're working hard every day for our pets!